Pharmacists in Monroe, North Carolina


61 Pharmacists found in Monroe
female pharmacist

Dr. Robin Lynnette Haltom, PHARMD


Pharmacist
625 E Roosevelt Blvd, Monroe, NC 28112
704-226-0485    

female pharmacist

Dr. Sarah Marie-leonall Palacio, PHARMD


Pharmacist
1995 Wellness Blvd Ste 110, Monroe, NC 28110
704-384-1140    

female pharmacist

Sejal A Dave, RPH


Pharmacist
500 Fincher St, Monroe, NC 28112
704-225-9010     704-225-7179



male pharmacist

Shaun Key


Pharmacist
2406 W Roosevelt Blvd, Monroe, NC 28110
704-289-5441    

female pharmacist

Dr. Shrujal Shah, PHARM D


Pharmacist
625 E Roosevelt Blvd, Monroe, NC 28112
704-289-8513    

female pharmacist

Dr. Stephanie Michelle Hemann, PHARM D


Pharmacist
2501 W Roosevelt Blvd, Monroe, NC 28110
704-283-1506    

female pharmacist

Dr. Tammy Robinson Glass, PHARMD


Pharmacist
610 E Franklin St, Monroe, NC 28112
704-289-1523    

male pharmacist

Thomas Pomfrey, RPH


Pharmacist
2901 W Highway 74, Target Pharmacy T-2074, Monroe, NC 28110
704-282-1445     704-290-1035

female pharmacist

Tiffany Thomas


Pharmacist
2501 W Roosevelt Blvd, Monroe, NC 28110
704-283-1506    

male pharmacist

Dr. Troy Riley, PHARM.D


Pharmacist
2901 Wesley Chapel Stouts Rd, Monroe, NC 28110
704-283-9163    

female pharmacist

Whitney Cdel Smith


Pharmacist
625 E Roosevelt Blvd, Monroe, NC 28112
704-289-8513     740-590-9508

female pharmacist

Yukti Naik


Pharmacist
1993 Dickerson Blvd, Monroe, NC 28110
704-296-5080    

female pharmacist

Zil Shah


Pharmacist
625 E Roosevelt Blvd, Monroe, NC 28112
704-289-8513    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.